Sara Kasum

Canada's Drug Agency policies as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry. Federal policies that relate to possible models of pharmacare Federal Buy Canadian Procurement Policy as it relates to government drug procurement practices and the implications for the biopharmaceutical industry Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations National Strategy for Drugs for Rare Diseases World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the biopharmaceutical industry World Health Organization (WHO) issues concerning the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Income Tax Act as it relates to biopharmaceutical products Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade agreements as they relate to the biopharmaceutical industry Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry

Discussions of programming to support social and economic development both on and off-reserve.

research into blockchain technology in traceability programs, Business risk management programs, Livestock Tax Deferral, Livestock Price Insurance, Agristability, Animal Health programs. Regulations and legislation related to beef cattle and meat production, exports and imports. Market access for beef and cattle, achieving new and defending existing trade agreements. Farm policy and programs with respect to business risk management, innovation, environment, etc. "Taxation policies and programs related to farm income, capital gains, generational transfer of assets, family income sharing, investment income, and tax deferrals for extraordinary revenue due to inventory liquidation during a declared disaster."

Discuss increasing incidents of violence against health care workers, prevention, and enforcement of existing laws. Support nursing students through targeted financial support such as paid preceptorships and federal grants. Support internationally educated nurses through establishing a collaborative, multi-stakeholder body hosted by Health Canada, to lead national strategy, planning and coordination for internationally educated nurses' registration, integration and support. Targeted funding of $1 billion as an initial investment to immediately begin to address the current health care workforce crisis experienced by provinces/territories across Canada, with funding focused on short and long-term goals. To achieve patient-centred quality care based on the WHO’s comprehensive health labour markets framework that would be acceptable to, and delivered by, the provinces/territories. Provide sustainable funding so nurses and other healthcare workers have access to mental health supports. In keeping with the recommendations of the Truth and Reconciliation Commission, establish specific targets and timelines for the admission and graduation of First Nations, Métis and Inuit health professionals in all postsecondary institutions and provide funding dedicated to indigenous nurse students. Implementing a Universal single-payer pharmacare program. Fund innovative retention and recruitment programs targeted at early-career, mid-career and late-career nurses. Establish a dedicated coordinating body to address critical health workforce data gaps based on global best practices on health workforce management. Address health workforce shortages through the implementation of a comprehensive, pan-Canadian health human resources strategy, in coordination with the provinces and territories, backed by sufficient funding and with real accountability for achieving desired health outcomes; and address critical data gaps through significantly enhancing existing health workforce data infrastructure to standardize data collection and analysis across workers, sectors and jurisdictions, with links to relevant patient information, healthcare utilization and outcome data, for more fit-for-purpose planning and tools available at the provincial, territorial, regional and training program level. In designing this, Canada should draw on global best practices in health workforce planning including in Australia and New Zealand.

Science-based food regulations: Working with the Government of Canada on a variety of regulations to promote safety, efficiency, and competitiveness. Trade diversification: Working with the government to seek out and sign new free trade agreements with markets that have a potential for increased Canadian meat exports. Canada-U.S. relations: Ensuring that the Canada-United States-Mexico Agreement (CUSMA) continues in its entirety. Labour: Advocating for a permanent food processing immigration stream, stemming from the success of the Agri-Food Pilot. International Barriers to Trade: Seeking to eliminate or prevent out-dated, overly burdensome, discriminatory or otherwise inappropriate technical requirements in other countries that can create unnecessary obstacles to trade, reduce competition and prevent Canadian exporters from participating in global supply under the WTO SPS and TBT Agreements. The Canadian Meat Council is advocating for strengthened regulatory cooperation initiatives in regional, plurilateral and multilateral trade agreements to further facilitate trade. Accelerated Capital Cost Allowance: Encouraging the adoption of an increased and permanent accelerated capital cost allowance to match the tax benefits available to the American meat processing sector. Canadian Food Inspection Agency and User Fee Act: Advocating for a review of the CFIA fee structure and establishment of service standards as required by the User Fee Act. Interprovincial trade of meat: Advocating for all meat that is processed in Canada and that crosses provincial borders to be inspected by the Canadian Food Inspection Agency under the Safe Food for Canadians Act and Regulations. Canada-U.S. Regulatory Cooperation: Seeking greater regulatory alignment between American and Canadian food inspection systems to ensure that Canada remains regulatory competitive. Canada-EU: Promoting commercially viable access to Europe for Canadian beef and pork under the provisions of the Canada Europe Comprehensive Economic and Trade Agreement (CETA). Canada-China: Advocating for tariff-free access to the Chinese market for Canadian beef and pork exports. Domestic processing: Advocating for a targeted federal support program to assist small and medium-sized beef processors who are experiencing severe financial stress due to limited cattle supply and rising input costs. The program would aim to stabilize operations, preserve regional processing capacity, and sustain employment through short-term financial relief and resilience measures developed in collaboration with the Government of Canada Terrestrial animal diseases: Ensuring the Government of Canada is adequately prepared to respond to foreign animal diseases, including funding support for processors and zoning agreements with key trading partners.